Cognitive impairment reported after COVID-19 infection
Jul 29, 2021
Cognitive impairment was identified in a cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19.
Dementia risk score linked to MRI markers of brain atrophy
Aug 26, 2021
Higher scores on the Lifestyle for Brain Health index were linked to higher volumes of white matter hyperintensities, lower scores for cognitive function.
Medicare now covers COVID-19 tests bought at drug stores
Apr 05, 2022
Now the 59 million Americans covered by Medicare Part B can get up to eight free, at-home tests each month.
WHO declares monkeypox a global health emergency
Jul 25, 2022
The WHO panel was hesitant to make the declaration because the virus is still spreading mostly in the primary risk group, men who have sex with men, and not among more vulnerable groups such as older adults.
FDA approves first breath test for COVID-19
Apr 15, 2022
The test, which must be administered by a trained operator, demonstrates a high degree of accuracy.
Betadine solution, Ag-Gel combo effective for eliminating bacteria
Aug 17, 2022
The combination was more effective than 5% betadine solution or silver colloidal gel alone for all bacteria, including K. pneumoniae.
Two new omicron subvariants fueling COVID-19 infections in New York state
Apr 14, 2022
The two subvariants — called BA.2.12 and BA.2.12.1 — accounted for more than 70% of new cases in March.
White House takes more steps to up supply of rapid at-home COVID-19 tests
Oct 26, 2021
Tests will be be particularly useful during flu season because the tests can help distinguish between the flu and COVID-19.
Life expectancy in the U.S. varies by race, ethnicity, state
Jun 27, 2022
The disparity in life expectancy across states is greater when race and ethnicity are considered.
SSRIs linked to reduced relative risk for mortality in COVID-19
Nov 15, 2021
The relative risks for mortality was significantly reduced for any selective serotonin reuptake inhibitor, fluoxetine and fluoxetine or fluvoxamine.